Print

Hyperion Therapeutics Announces Pricing of Follow-On Offering  
3/8/2013 10:17:18 AM

SOUTH SAN FRANCISCO, Calif., March 8, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) announced today the pricing of its follow-on offering of 2,875,000 shares of its common stock at $20.75 per share, before underwriting discounts and commissions. All of the common stock is being offered by Hyperion. In addition, the underwriters have a 30-day option to purchase up to an additional 431,250 shares of common stock from Hyperion to cover over-allotments, if any. The offering is expected to close on March 13, 2013, subject to customary closing conditions.
//-->